MBBP client, Whitehead Institute, featured in New York Times article discussing Genomic research 01/12/2017Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: biomedical research, client, DNA, genome, Life Sciences, new york times, scientific research, TADs, Whitehead Institute, Whitehead Institute for Biomedical Research
add a comment
As the article explains, TADs are a newly discovered design feature of the genome that partition different groups of genes into neighborhoods. If these partitions are broken, various diseases may occur.
By conducting research on TADs, scientists hope to gain a more in depth understanding of how gene expression is controlled. Dr. Richard Young of the Whitehead Institute and his team are involved in TADs research and are continuing to push the boundaries of knowledge about genetic neighborhoods.
For more information, read the full article.
MBBP Client PMS Bites’ CEO Tania Green Recognized as Female Entrepreneur All Businesses Can Learn From 11/08/2016Posted by Morse Barnes-Brown Pendleton in Client News.
Tags: boston business, client, entrepreneur, entrepreneurs, entrepreneurship, female entrepreneur, pms bites
add a comment
Tania Green of firm client PMS Bites is recognized in the Living Business section of Colonial Life as 1 of 18 Bostonian female entrepreneurs from whom all businesses can learn. The takeaway from Green’s mention is that any problem an individual may have, other individuals are also having, and therefore a solution would be useful to a wide audience. Green had a successful Kickstarter campaign for PMS Bites and was also featured on the hit show “Shark Tank”.
PMS Bites are edible chocolate snacks that are gluten free and vegan, and have all natural ingredients targeted toward combating female PMS symptoms.
Congratulations to Tania and PMS Bites!
Tags: boston brava award, boston law firm, c-suite executives, CEO, client, entrepreneur, entrepreneurs, female business leader, founder, katie bouton, venture capital
add a comment
Firm client Katie Bouton of Koya Leadership Partners received the 2016 Boston Brava Award from SmartCEO. The Boston Brava Award recognizes high-impact female business leaders who are CEOs, Executive Directors of Nonprofits, or C-suite executives. An independent committee of local business leaders chooses the winner of the Brava Award. Winners are chosen for their commitment to giving back to their communities, and for their company’s growth, mentoring, and community impact.
Koya Leadership Partners was founded on the belief that “the right person in the right place can change the world”. The company conducts executive searches and provides human capital consulting and career coaching services.
Congratulations to Katie and Koya Leadership Partners!
Firm Client Applied BioMath Recognized in Greater Boston’s 2016 Small Business of the Year Awards 08/02/2016Posted by Morse Barnes-Brown Pendleton in Client News, Corporate, Life Sciences.
Tags: Applied BioMath, chamber of commerce, client, drug invention, greater boston chamber of commerce, innovation, Life Sciences, small business, small business of the year awards
add a comment
MBBP is thrilled to announce that client Applied BioMath, LLC is one of ten winners of the 2016 Small Business of the Year Awards (SBOY), announced by The Greater Boston Chamber of Commerce. The SBOY recognizes smaller for-profit companies within the Greater Boston area who possess product innovation, workplace excellence, community and social responsibility, strong financial performance, and achievement in management.
Applied BioMath, LLC was founded in 2013 with the goal of transforming the quality and the economics of drug invention by applying advanced mathematical analysis at critical decision points in the drug invention process. The ten award winners will be recognized at the event “Nailed It: A Conversation with Successful Business Leaders”, which will be held on October 6th.
MBBP assisted Applied BioMath in drafting its various Service Agreements with customers, among other key legal services. Congratulations to our client in what is sure to be one of many successes!
Tags: client, clinical study, ConforMIS, employment law, joint replacement implants, knee replacement, medical technology
add a comment
ConforMIS, Inc., a medical technology company that manufactures and sells joint replacement implants, received positive results from its iTotal CR study. The iTotal CR is a fully customized implant for use in total knee replacement, and the study found that 92% of patients were satisfied with the product in the year after receiving a knee replacement.
In developing, manufacturing, and selling joint replacement implants, ConforMIS uses its iFit Image-to-Implant technology, which allows for a customized implant specifically designed to fit an individual’s anatomy. The iTotal CR study included 300 patients in the United States, and is still ongoing. The interim study results were presented at the 2016 SICOT International Orthopaedic “Specialized Knee Surgery” Conference in Germany, which ran from June 30th to July 2nd.
The positive feedback is consistent with a previous study that showed that patients noted significantly higher satisfaction with the ConforMIS iTotal CR in their knee replacements, than with off-the-shelf implants. The positive results speak to the benefits of anatomically customized implants, and illustrate how ConforMIS’s products are making a positive and lasting impact in the joint replacement implant market.
To read more about the study and ConforMIS’s technology, read the full article.
MBBP Client Valeritas, Inc. Announced Positive Results for V-Go® Disposable Insulin Delivery Device 06/16/2016Posted by Morse Barnes-Brown Pendleton in Client News.
Tags: client, insulin, insulin delivery, Life Sciences, medical devices, patient care
add a comment
MBBP client Valeritas, Inc. has recently announced positive results for four studies on their flagship product. Valeritas is a commercial-stage medical technology company focused on developing innovative solutions to improve health and quality of life of people with Type 2 diabetes.
Their flagship product is the V-Go® Disposable Insulin Delivery Device which is a small, wearable, disposable insulin delivery solution for the delivery of basal-bolus insulin therapy in adults with Type 2 diabetes.
The four studies were as followed:
Study 1: Evaluating the Impact on Diabetes Control with V-Go® For Patients with Diabetes not Achieving Optimal Control: A Retrospective Cohort Analysis in a Large Endocrine and Specialized Diabetes System
Study 2: Evaluating V-Go® In Patients 65 Years of Age or Older with Poorly Controlled Diabetes: A Health Outcome and Economic Analysis from an Endocrine and Diabetes Specialty System
Study 3: Optimizing Insulin Therapy in Older Adults in Long-Term Care: A Com parative Retrospective Analysis of V-Go® vs. Standard of Care
Study 4: Improved Glycemic Control in Patients with Type 2 Diabetes Switching to the V-Go® Insulin Delivery Device: A Prospective Study Utilizing Continuous Glucose Monitoring
These studies showed that when using, or switching to V-Go®, patients with diabetes experienced improved glycemic control, a reduction in A1C and cost savings when compared to comparison treatments. Overall, Dr. David Sutton remarks, “The studies that I am involved with provide data that continues to support the real-world clinical value of using V-Go® in patients that require insulin. Importantly, the data presented at ADA shows the value of V-Go® in older patients that require both a clinically-effective and cost-effective therapy.”
Great work, Valeritas, Inc.!
For more information, read Valeritas press release.
Tags: acquiring, acquisition, client, logistics, M&A transactions, SaaS, trademark, transportation
add a comment
Firm client Kewill announced that as of June 1, 2016, its acquisition of LeanLogistics is closed. The acquisition will allow the two companies to better serve their customers’ supply chain logistics needs.
Kewill specializes in enabling its clients to efficiently move their information and goods across the global supply chain through its logistics software.
LeanLogistics’ is a software as a service (SaaS) company with a cloud-based transportation management system.
Kewill’s acquisition of LeanLogistics creates “the most expansive and largest carrier network feeding into the most sophisticated Transportation Management platform available in North America.” Congratulations to both companies on the acquisition!
Eric Lander of MBBP Client Whitehead Institute for Biomedical Research Receives MIT’s Killian Award 05/19/2016Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: biology, client, Eric Lander, genome, MIT, President's Council of Advisors on Science and Technology, research, science, science and technology, Whitehead Institute for Biomedical Research
add a comment
MIT’s 2016-2017 James R. Killian Jr. Faculty Achievement Award was presented to biology professor Eric Lander. Lander, of MBBP client Whitehead Institute for Biomedical Research, is a renowned biologist recognized for his research in mapping the human genome. The Killian Award, established in 1971, honors faculty members who demonstrate extraordinary professional achievements.
Lander led the international Human Genome Project from 1990 to 2003, which included the development of techniques to map the human genome. He has taught his MIT introductory biology course for over 20 years. In addition to these achievements, Lander serves as co-chair of the White House’s President’s Council of Advisors on Science and Technology.
Lander joined the Whitehead Institute for Biomedical Research in 1986. The Whitehead Institute is a non-profit research facility that works to improve human health through biomedical research.
The Killian Award committee explained that “unlocking the information in genomes has been one of the defining scientific revolutions of the past quarter century. With the Killian Award, the committee acknowledges the transformative effect Professor Lander has had on the study of biology and medicine. We honor Professor Eric S. Lander for these extraordinary contributions, and for his roles as a gifted leader, teacher, mentor, and public advocate for science at the highest levels.”
In response, Lander stated that he is “tremendously honored, especially because this is an award conferred by my faculty colleagues at MIT. There is no higher recognition.”